Skip to main content
. 2015 Dec 16;137(2):348–354. doi: 10.1378/chest.09-1250

Table 2.

Detection of Different Viral and Bacterial Pathogens in Subjects

Asthma Exacerbation(n = 206a) Stable Asthma(n = 77) P Valueb
Individual organism
 Rhinovirus 54 (26.2) 10 (13.0) .027c
 Human metapneumovirus 12 (5.8) 2 (2.6) .364
 Influenza A virus 16 (7.8) 4 (5.2) .624
 Influenza B virus 3 (1.5) 0 .565
 Parainfluenza viruses types 1-4 14 (6.8) 2 (2.6) .250
 Respiratory syncytial virus 8 (3.9) 1 (1.3) .452
 Bocavirus 5 (2.4) 2 (2.6) 1.000
 Adenovirus 5 (2.4) 0 .328
 Human coronaviruses OC43 or 229E 5 (2.4) 0 .328
 Enterovirus 2 (1.0) 0 1.000
Mycoplasma pneumoniae 2 (1.0) 2 (2.6) .299
Chlamydophila pneumoniae 4 (1.9) 1 (1.3) 1.000
Presence of any virus 103 (50.0) 20 (26.0) < .001c
M pneumoniae or C pneumoniae 5 (2.4) 1 (1.3) 1.000
Presence of any pathogen 105 (51.0) 21 (27.3) < .001c
Coinfection by two or more pathogens 22 (10.7) 2 (2.6) 0.053
a

Insufficient respiratory specimens were obtained from three patients.

b

Analyzed by χ2 (with Yates correction) or Fisher exact test as appropriate.

c

Odds ratios (95% CI) for asthma exacerbation were: 2.38 (1.09–5.32) for rhinovirus, 2.85 (1.54–5.30) for any virus, and 2.77 (1.51–5.11) for any pathogen.